These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1284520

  • 1. Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor.
    Baudouin C, Fredj-Reygrobellet D, Ettaiche M, Barritault D, Gastaud P, Lapalus P.
    Lens Eye Toxic Res; 1992; 9(3-4):505-11. PubMed ID: 1284520
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S, Ohuchi T, Okada M, Yamakawa R, Yoshimura N, Honda Y.
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH, Chen EP, Hatchell DL, Samsa GP, Saloupis PT, Westendorf J, Machemer R.
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [Abstract] [Full Text] [Related]

  • 5. A refined experimental model for proliferative vitreoretinopathy.
    Chandler DB, Quansah FA, Hida T, Machemer R.
    Graefes Arch Clin Exp Ophthalmol; 1986 Apr; 224(1):86-91. PubMed ID: 2417916
    [Abstract] [Full Text] [Related]

  • 6. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T, Ogura Y, Yoshimura N, Honda Y, Wada R, Hyon SH, Ikada Y.
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.
    Wong CG, Rich KA, Liaw LH, Hsu HT, Berns MW.
    Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391
    [Abstract] [Full Text] [Related]

  • 8. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE, Davis PA, Hernandez E, O'Grady GE, Cousins SW.
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [Abstract] [Full Text] [Related]

  • 9. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy.
    Algvere PV, Hallnäs K, Dafgård E, Höög A.
    Graefes Arch Clin Exp Ophthalmol; 1990 Mar; 228(5):461-6. PubMed ID: 2227493
    [Abstract] [Full Text] [Related]

  • 10. Experimental retinal detachment in owl monkeys. Effect of intravitreal hyaluronidase injection and embolization of the choroidal and retinal circulation.
    Algvere P, Balazs EA.
    Mod Probl Ophthalmol; 1974 Mar; 12(0):152-66. PubMed ID: 4214319
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.
    Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL.
    Graefes Arch Clin Exp Ophthalmol; 1993 Mar; 231(1):34-40. PubMed ID: 8428678
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
    Chen EP, Steinhorst UH, Samsa GP, Saloupis PT, Hatchell DL.
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2160-4. PubMed ID: 1607226
    [Abstract] [Full Text] [Related]

  • 15. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.
    Yang CM, Olsen KR, Hernandez E, Cousins SW.
    Graefes Arch Clin Exp Ophthalmol; 1992 Jun; 230(1):66-71. PubMed ID: 1547971
    [Abstract] [Full Text] [Related]

  • 16. Proliferative vitreoretinopathy in fundus flavimaculatus.
    Danis RP, Kuwabara T.
    Am J Ophthalmol; 1992 Jun 15; 113(6):713-4. PubMed ID: 1598966
    [No Abstract] [Full Text] [Related]

  • 17. Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.
    Hida T, Chandler DB, Sheta SM.
    Graefes Arch Clin Exp Ophthalmol; 1987 Jun 15; 225(4):303-7. PubMed ID: 3653728
    [Abstract] [Full Text] [Related]

  • 18. Giant retinal tears. II. Experimental production and management with intravitreal air.
    Machemer R, Aaberg TM, Norton EW.
    Am J Ophthalmol; 1969 Dec 15; 68(6):1022-9. PubMed ID: 4983092
    [No Abstract] [Full Text] [Related]

  • 19. Early vitreous changes in experimental proliferative vitreoretinopathy.
    Miglior S, Kain HL, Libondi T, González RG, Barnett P, Krauss JM, Cheng HM.
    Arch Ophthalmol; 1986 Nov 15; 104(11):1681-4. PubMed ID: 3778288
    [Abstract] [Full Text] [Related]

  • 20. Effects of Gingko biloba extracts in a model of tractional retinal detachment.
    Baudouin C, Ettaiche M, Fredj-Reygrobellet D, Droy-Lefaix MT, Gastaud P, Lapalus P.
    Lens Eye Toxic Res; 1992 Nov 15; 9(3-4):513-9. PubMed ID: 1284521
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.